Purple Biotech Ltd.

NASDAQ: PPBT · Real-Time Price · USD
2.43
0.12 (5.19%)
At close: Aug 15, 2025, 3:59 PM
2.28
-6.17%
After-hours: Aug 15, 2025, 04:48 PM EDT

Purple Biotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 195.8K n/a n/a
Cost of Revenue
n/a 196K 120.00 55.00
Gross Profit
n/a -196 -120 -55
Operating Income
-11.01M -22.27M -22.6M -17.93M
Interest Income
260K 474K 532K 320K
Pretax Income
-7.28M -19.98M -21.76M -17.83M
Net Income
-7.24M -19.88K -21.67M -18.38M
Selling & General & Admin
2.94M 4.84M 5.96M 5.82M
Research & Development
7.62M 17.03M 16.32M 11.83M
Other Expenses
450K 393K 321K 12K
Operating Expenses
11.01M -22.47M 22.6M 17.93M
Interest Expense
447K 2.18M 67K 212K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
11.01M 22.27M 22.6M 17.93M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
2.59M 1.23M 924.08K 890K
Shares Outstanding (Diluted)
2.59M 1.23M 924.08K 890K
EPS (Basic)
-0.03 -0.16 -0.23 -0.21
EPS (Diluted)
-0.03 -0.16 -0.23 -0.21
EBITDA
-7.05M -22.23M -21.49M -17.52M
EBIT
-7.24M -19.92M -21.69M -17.75M
Depreciation & Amortization
186K 46K 201K 231K